Drug
Hydroxocobalamin
Hydroxocobalamin is a pharmaceutical drug with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_1
1
17%
Ph phase_2
3
50%
Ph phase_4
2
33%
Phase Distribution
1
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
2(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(2)
Detailed Status
Completed4
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (16.7%)
Phase 23 (50.0%)
Phase 42 (33.3%)
Trials by Status
terminated117%
withdrawn117%
completed467%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
A Study on Hydroxocobalamin Given to Healthy Individual to Monitor Symptoms
NCT07469189
completedphase_2
A Trial of Vitamin B12 in Septic Shock
NCT03783091
completedphase_4
Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
NCT04054999
terminatedphase_2
Vitamin B12a Vasoplegic Syndrome
NCT03735316
completedphase_4
Vitamin Deficiencies and Suppletion in Morbid Obesity
NCT02270749
Clinical Trials (6)
Showing 6 of 6 trials
NCT07469189Phase 1
A Study on Hydroxocobalamin Given to Healthy Individual to Monitor Symptoms
NCT03783091Phase 2
A Trial of Vitamin B12 in Septic Shock
NCT04054999Phase 4
Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
NCT03735316Phase 2
Vitamin B12a Vasoplegic Syndrome
NCT02270749Phase 4
Vitamin Deficiencies and Suppletion in Morbid Obesity
NCT03446599Phase 2
Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6